

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA unwinding involved in DNA replication (GO:0006268) | 5.56113877 |
| 2 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.80970976 |
| 3 | DNA strand elongation (GO:0022616) | 4.56425709 |
| 4 | protein localization to kinetochore (GO:0034501) | 4.36163461 |
| 5 | mitotic chromosome condensation (GO:0007076) | 4.28998281 |
| 6 | protein localization to chromosome, centromeric region (GO:0071459) | 4.20699561 |
| 7 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 4.09191226 |
| 8 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.98107853 |
| 9 | peptidyl-histidine modification (GO:0018202) | 3.94457215 |
| 10 | pseudouridine synthesis (GO:0001522) | 3.90895070 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 3.81805879 |
| 12 | negative regulation of RNA splicing (GO:0033119) | 3.80773918 |
| 13 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.77929303 |
| 14 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.77929303 |
| 15 | DNA replication initiation (GO:0006270) | 3.77631205 |
| 16 | mitotic sister chromatid cohesion (GO:0007064) | 3.76534587 |
| 17 | sister chromatid segregation (GO:0000819) | 3.73975797 |
| 18 | proteasome assembly (GO:0043248) | 3.72287541 |
| 19 | mitotic nuclear envelope disassembly (GO:0007077) | 3.71278908 |
| 20 | meiotic chromosome segregation (GO:0045132) | 3.68166731 |
| 21 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.62748407 |
| 22 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.61576763 |
| 23 | nuclear pore organization (GO:0006999) | 3.61011250 |
| 24 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.59796151 |
| 25 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.59796151 |
| 26 | translesion synthesis (GO:0019985) | 3.58558901 |
| 27 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.56431932 |
| 28 | DNA duplex unwinding (GO:0032508) | 3.56295305 |
| 29 | nuclear envelope disassembly (GO:0051081) | 3.56114838 |
| 30 | membrane disassembly (GO:0030397) | 3.56114838 |
| 31 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.55801514 |
| 32 | mitochondrial RNA metabolic process (GO:0000959) | 3.55580646 |
| 33 | IMP biosynthetic process (GO:0006188) | 3.54698360 |
| 34 | DNA geometric change (GO:0032392) | 3.53454910 |
| 35 | mitotic sister chromatid segregation (GO:0000070) | 3.53319585 |
| 36 | regulation of sister chromatid cohesion (GO:0007063) | 3.52292100 |
| 37 | rRNA modification (GO:0000154) | 3.49455818 |
| 38 | viral transcription (GO:0019083) | 3.48965188 |
| 39 | mitotic recombination (GO:0006312) | 3.48113051 |
| 40 | maturation of SSU-rRNA (GO:0030490) | 3.44362942 |
| 41 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.43168626 |
| 42 | telomere maintenance via recombination (GO:0000722) | 3.41910711 |
| 43 | mitotic metaphase plate congression (GO:0007080) | 3.41415316 |
| 44 | replication fork processing (GO:0031297) | 3.41358108 |
| 45 | translational termination (GO:0006415) | 3.40708090 |
| 46 | negative regulation of mRNA processing (GO:0050686) | 3.38185937 |
| 47 | dosage compensation (GO:0007549) | 3.35492165 |
| 48 | formation of translation preinitiation complex (GO:0001731) | 3.34146748 |
| 49 | viral mRNA export from host cell nucleus (GO:0046784) | 3.33106485 |
| 50 | ribosome assembly (GO:0042255) | 3.31875300 |
| 51 | peptidyl-lysine dimethylation (GO:0018027) | 3.31513321 |
| 52 | amino acid activation (GO:0043038) | 3.27564532 |
| 53 | tRNA aminoacylation (GO:0043039) | 3.27564532 |
| 54 | translational elongation (GO:0006414) | 3.26373624 |
| 55 | nuclear pore complex assembly (GO:0051292) | 3.26069503 |
| 56 | tRNA aminoacylation for protein translation (GO:0006418) | 3.25091241 |
| 57 | IMP metabolic process (GO:0046040) | 3.25049046 |
| 58 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.24577192 |
| 59 | non-recombinational repair (GO:0000726) | 3.24577192 |
| 60 | DNA topological change (GO:0006265) | 3.24334216 |
| 61 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.24154303 |
| 62 | telomere maintenance via telomere lengthening (GO:0010833) | 3.21276343 |
| 63 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.18772140 |
| 64 | COPI coating of Golgi vesicle (GO:0048205) | 3.17655492 |
| 65 | Golgi transport vesicle coating (GO:0048200) | 3.17655492 |
| 66 | regulation of translational fidelity (GO:0006450) | 3.17296735 |
| 67 | DNA replication checkpoint (GO:0000076) | 3.15392586 |
| 68 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.14390254 |
| 69 | postreplication repair (GO:0006301) | 3.14007979 |
| 70 | protein localization to chromosome (GO:0034502) | 3.13788241 |
| 71 | translational initiation (GO:0006413) | 3.11232321 |
| 72 | regulation of spindle organization (GO:0090224) | 3.11141191 |
| 73 | negative regulation of mRNA metabolic process (GO:1903312) | 3.10017720 |
| 74 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.09885913 |
| 75 | mRNA stabilization (GO:0048255) | 3.08528329 |
| 76 | RNA stabilization (GO:0043489) | 3.08528329 |
| 77 | GMP metabolic process (GO:0046037) | 3.07663878 |
| 78 | ribosome biogenesis (GO:0042254) | 3.07460664 |
| 79 | peptidyl-arginine N-methylation (GO:0035246) | 3.06053995 |
| 80 | peptidyl-arginine methylation (GO:0018216) | 3.06053995 |
| 81 | nuclear envelope organization (GO:0006998) | 3.06048852 |
| 82 | positive regulation of chromosome segregation (GO:0051984) | 3.04764023 |
| 83 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.02990290 |
| 84 | * regulation of chromosome segregation (GO:0051983) | 3.01698014 |
| 85 | negative regulation of histone methylation (GO:0031061) | 3.01220046 |
| 86 | regulation of mitochondrial translation (GO:0070129) | 3.00941300 |
| 87 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.00626503 |
| 88 | valine metabolic process (GO:0006573) | 3.00205962 |
| 89 | metaphase plate congression (GO:0051310) | 3.00090308 |
| 90 | maturation of 5.8S rRNA (GO:0000460) | 2.99520267 |
| 91 | DNA conformation change (GO:0071103) | 2.98061722 |
| 92 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.96914965 |
| 93 | regulation of translational termination (GO:0006449) | 2.95953573 |
| 94 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.95463948 |
| 95 | chromosome condensation (GO:0030261) | 2.93929310 |
| 96 | rRNA methylation (GO:0031167) | 2.93561123 |
| 97 | mismatch repair (GO:0006298) | 2.92983101 |
| 98 | regulation of DNA damage checkpoint (GO:2000001) | 2.92934231 |
| 99 | establishment of chromosome localization (GO:0051303) | 2.92760345 |
| 100 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.92281450 |
| 101 | DNA replication-independent nucleosome organization (GO:0034724) | 2.92281450 |
| 102 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.91872699 |
| 103 | histone H2A acetylation (GO:0043968) | 2.91296215 |
| 104 | regulation of histone H3-K9 methylation (GO:0051570) | 2.90798450 |
| 105 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.89958627 |
| 106 | chromatin assembly or disassembly (GO:0006333) | 2.89382247 |
| 107 | DNA ligation (GO:0006266) | 2.88917383 |
| 108 | ATP-dependent chromatin remodeling (GO:0043044) | 2.87907660 |
| 109 | * spindle assembly checkpoint (GO:0071173) | 2.87601777 |
| 110 | base-excision repair (GO:0006284) | 2.87463028 |
| 111 | branched-chain amino acid catabolic process (GO:0009083) | 2.86685374 |
| 112 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.85872010 |
| 113 | mRNA splicing, via spliceosome (GO:0000398) | 2.85872010 |
| 114 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.85779130 |
| 115 | ubiquinone biosynthetic process (GO:0006744) | 2.85667367 |
| 116 | tRNA metabolic process (GO:0006399) | 2.84958767 |
| 117 | * mitotic spindle assembly checkpoint (GO:0007094) | 2.84416029 |
| 118 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.83539021 |
| 119 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.83281928 |
| 120 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.82873056 |
| 121 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.82873056 |
| 122 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.82873056 |
| 123 | heterochromatin organization (GO:0070828) | 2.82374128 |
| 124 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.81636785 |
| 125 | RNA splicing, via transesterification reactions (GO:0000375) | 2.80909152 |
| 126 | * negative regulation of chromosome segregation (GO:0051985) | 2.80463863 |
| 127 | nucleobase biosynthetic process (GO:0046112) | 2.80454687 |
| 128 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.79956636 |
| 129 | protein complex disassembly (GO:0043241) | 2.79467335 |
| 130 | synapsis (GO:0007129) | 2.79318423 |
| 131 | pore complex assembly (GO:0046931) | 2.79163138 |
| 132 | cellular protein complex disassembly (GO:0043624) | 2.78687130 |
| 133 | * negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.78557208 |
| 134 | * negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.78557208 |
| 135 | * negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.78557208 |
| 136 | * negative regulation of sister chromatid segregation (GO:0033046) | 2.78557208 |
| 137 | oxidative phosphorylation (GO:0006119) | 2.78211177 |
| 138 | purine nucleobase biosynthetic process (GO:0009113) | 2.78040203 |
| 139 | chromatin remodeling at centromere (GO:0031055) | 2.77610484 |
| 140 | branched-chain amino acid metabolic process (GO:0009081) | 2.77597759 |
| 141 | proline biosynthetic process (GO:0006561) | 2.76442661 |
| 142 | protein targeting to ER (GO:0045047) | 2.75867260 |
| 143 | DNA-dependent DNA replication (GO:0006261) | 2.74354489 |
| 144 | telomere maintenance (GO:0000723) | 2.72518267 |
| 145 | kinetochore organization (GO:0051383) | 2.71493760 |
| 146 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.70634729 |
| 147 | methionine biosynthetic process (GO:0009086) | 2.69785913 |
| 148 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.69571579 |
| 149 | telomere organization (GO:0032200) | 2.69529600 |
| 150 | tRNA modification (GO:0006400) | 2.69180194 |
| 151 | metallo-sulfur cluster assembly (GO:0031163) | 2.67902522 |
| 152 | iron-sulfur cluster assembly (GO:0016226) | 2.67902522 |
| 153 | tRNA processing (GO:0008033) | 2.67807728 |
| 154 | base-excision repair, AP site formation (GO:0006285) | 2.67655989 |
| 155 | ribosomal large subunit biogenesis (GO:0042273) | 2.67600779 |
| 156 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.67499488 |
| 157 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.67499488 |
| 158 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.67499488 |
| 159 | tRNA methylation (GO:0030488) | 2.67400277 |
| 160 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.67217026 |
| 161 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.67095680 |
| 162 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.66645540 |
| 163 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.66234090 |
| 164 | protein deneddylation (GO:0000338) | 2.63487489 |
| 165 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.62488341 |
| 166 | rRNA processing (GO:0006364) | 2.62178869 |
| 167 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.61403516 |
| 168 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.61403516 |
| 169 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.61055999 |
| 170 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.60754959 |
| 171 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.60754959 |
| 172 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.60500558 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.65961558 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.27494234 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.89639898 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.68348320 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.40522825 |
| 6 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.97394409 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.96076988 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 2.86163823 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.84540742 |
| 10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.72804105 |
| 11 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.49418240 |
| 12 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.37417751 |
| 13 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.35806925 |
| 14 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.35599462 |
| 15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.32111770 |
| 16 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.20819041 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.16416080 |
| 18 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.08525818 |
| 19 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.07528411 |
| 20 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.02668040 |
| 21 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.99762929 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.94199392 |
| 23 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.93914089 |
| 24 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.83018091 |
| 25 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.82990468 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77493769 |
| 27 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.76647460 |
| 28 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.76500106 |
| 29 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.74890428 |
| 30 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.74221990 |
| 31 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.73326554 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.67177161 |
| 33 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.63907828 |
| 34 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.63681998 |
| 35 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.63081018 |
| 36 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63013234 |
| 37 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.62135743 |
| 38 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.62014822 |
| 39 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.61395735 |
| 40 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.61085934 |
| 41 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.60867469 |
| 42 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60417303 |
| 43 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.59463051 |
| 44 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.59109478 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58452787 |
| 46 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.53571973 |
| 47 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.52421698 |
| 48 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52384891 |
| 49 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51706763 |
| 50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.50936613 |
| 51 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.49456933 |
| 52 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47633698 |
| 53 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.47434733 |
| 54 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.46842156 |
| 55 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.43412634 |
| 56 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.42601944 |
| 57 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42276486 |
| 58 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.35493277 |
| 59 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.34648341 |
| 60 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.33887880 |
| 61 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.33373848 |
| 62 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.31934167 |
| 63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29140731 |
| 64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.27177846 |
| 65 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25920430 |
| 66 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.25792636 |
| 67 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25324392 |
| 68 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.25032644 |
| 69 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.22948186 |
| 70 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.22677038 |
| 71 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.22204212 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21319771 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.20851845 |
| 74 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20562488 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20349320 |
| 76 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19836332 |
| 77 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18943606 |
| 78 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.17592220 |
| 79 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16882717 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.15831038 |
| 81 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.14546969 |
| 82 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14068178 |
| 83 | * KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.12707554 |
| 84 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.11095109 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.10874727 |
| 86 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10624197 |
| 87 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09369958 |
| 88 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.08846845 |
| 89 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.08746977 |
| 90 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.08697379 |
| 91 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07397246 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06898630 |
| 93 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.06585149 |
| 94 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06584097 |
| 95 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.06478535 |
| 96 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05782029 |
| 97 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04311641 |
| 98 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02812628 |
| 99 | * SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01930394 |
| 100 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.01414821 |
| 101 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.00427744 |
| 102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99302598 |
| 103 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.98580740 |
| 104 | MAF_26560356_Chip-Seq_TH1_Human | 0.96483019 |
| 105 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.95700783 |
| 106 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.95348819 |
| 107 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.94748916 |
| 108 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.94040347 |
| 109 | ATF3_27146783_Chip-Seq_COLON_Human | 0.91737917 |
| 110 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.91159146 |
| 111 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.91045711 |
| 112 | MYB_26560356_Chip-Seq_TH2_Human | 0.90392886 |
| 113 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.89544810 |
| 114 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89532738 |
| 115 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.88836246 |
| 116 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.87854075 |
| 117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.87289670 |
| 118 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.86750026 |
| 119 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.86505980 |
| 120 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.86376927 |
| 121 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84807085 |
| 122 | MYB_26560356_Chip-Seq_TH1_Human | 0.84200850 |
| 123 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.83408132 |
| 124 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83160771 |
| 125 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.82315441 |
| 126 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80881538 |
| 127 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.78808670 |
| 128 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.75956113 |
| 129 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74467736 |
| 130 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.73609724 |
| 131 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.71538436 |
| 132 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.69890638 |
| 133 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.68189742 |
| 134 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67336102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010094_abnormal_chromosome_stability | 3.75301693 |
| 2 | MP0004147_increased_porphyrin_level | 3.60397591 |
| 3 | MP0003111_abnormal_nucleus_morphology | 3.57594457 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.50713346 |
| 5 | MP0003077_abnormal_cell_cycle | 3.18464785 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.17253112 |
| 7 | MP0003123_paternal_imprinting | 2.51985171 |
| 8 | MP0006036_abnormal_mitochondrial_physio | 2.35263803 |
| 9 | MP0001661_extended_life_span | 2.33103409 |
| 10 | MP0006035_abnormal_mitochondrial_morpho | 2.27349061 |
| 11 | MP0003718_maternal_effect | 2.25890826 |
| 12 | MP0001730_embryonic_growth_arrest | 2.25707267 |
| 13 | MP0008007_abnormal_cellular_replicative | 2.20103770 |
| 14 | MP0003221_abnormal_cardiomyocyte_apopto | 2.15474617 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.14960661 |
| 16 | MP0010352_gastrointestinal_tract_polyps | 2.13482458 |
| 17 | MP0009697_abnormal_copulation | 2.09889550 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.08624713 |
| 19 | MP0005075_abnormal_melanosome_morpholog | 2.08458212 |
| 20 | MP0000537_abnormal_urethra_morphology | 2.06723513 |
| 21 | MP0000350_abnormal_cell_proliferation | 1.97728344 |
| 22 | MP0000372_irregular_coat_pigmentation | 1.95712581 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.95221943 |
| 24 | MP0002877_abnormal_melanocyte_morpholog | 1.95123320 |
| 25 | MP0000751_myopathy | 1.93728979 |
| 26 | MP0002396_abnormal_hematopoietic_system | 1.92285435 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.91233722 |
| 28 | MP0001873_stomach_inflammation | 1.89663695 |
| 29 | MP0004808_abnormal_hematopoietic_stem | 1.89141635 |
| 30 | MP0003121_genomic_imprinting | 1.87083222 |
| 31 | MP0010307_abnormal_tumor_latency | 1.87041046 |
| 32 | MP0008932_abnormal_embryonic_tissue | 1.83820921 |
| 33 | MP0008057_abnormal_DNA_replication | 1.80664924 |
| 34 | MP0006054_spinal_hemorrhage | 1.78426679 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.77390842 |
| 36 | MP0004197_abnormal_fetal_growth/weight/ | 1.71416042 |
| 37 | MP0001697_abnormal_embryo_size | 1.70002219 |
| 38 | MP0010030_abnormal_orbit_morphology | 1.66921795 |
| 39 | MP0008058_abnormal_DNA_repair | 1.65813585 |
| 40 | MP0002080_prenatal_lethality | 1.63188105 |
| 41 | MP0003315_abnormal_perineum_morphology | 1.63099738 |
| 42 | MP0008877_abnormal_DNA_methylation | 1.62596955 |
| 43 | MP0003283_abnormal_digestive_organ | 1.60159390 |
| 44 | MP0000733_abnormal_muscle_development | 1.59295207 |
| 45 | MP0001672_abnormal_embryogenesis/_devel | 1.58199102 |
| 46 | MP0005380_embryogenesis_phenotype | 1.58199102 |
| 47 | MP0002084_abnormal_developmental_patter | 1.58081766 |
| 48 | MP0004233_abnormal_muscle_weight | 1.56717814 |
| 49 | MP0002085_abnormal_embryonic_tissue | 1.55727132 |
| 50 | MP0003567_abnormal_fetal_cardiomyocyte | 1.52611883 |
| 51 | MP0003984_embryonic_growth_retardation | 1.49415232 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.49214630 |
| 53 | MP0002088_abnormal_embryonic_growth/wei | 1.47516913 |
| 54 | MP0000747_muscle_weakness | 1.45678913 |
| 55 | MP0003186_abnormal_redox_activity | 1.44223960 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.43283012 |
| 57 | MP0005083_abnormal_biliary_tract | 1.34764071 |
| 58 | MP0004084_abnormal_cardiac_muscle | 1.34275574 |
| 59 | MP0003119_abnormal_digestive_system | 1.33355683 |
| 60 | MP0009278_abnormal_bone_marrow | 1.33266790 |
| 61 | MP0009672_abnormal_birth_weight | 1.29672188 |
| 62 | MP0008872_abnormal_physiological_respon | 1.28296869 |
| 63 | MP0002086_abnormal_extraembryonic_tissu | 1.27408842 |
| 64 | MP0008995_early_reproductive_senescence | 1.26787161 |
| 65 | MP0002398_abnormal_bone_marrow | 1.26763500 |
| 66 | MP0000428_abnormal_craniofacial_morphol | 1.26237875 |
| 67 | MP0000750_abnormal_muscle_regeneration | 1.22282556 |
| 68 | MP0001849_ear_inflammation | 1.20828321 |
| 69 | MP0004087_abnormal_muscle_fiber | 1.20373128 |
| 70 | MP0000313_abnormal_cell_death | 1.19965798 |
| 71 | MP0001929_abnormal_gametogenesis | 1.19400123 |
| 72 | MP0000689_abnormal_spleen_morphology | 1.18444782 |
| 73 | MP0002160_abnormal_reproductive_system | 1.17808603 |
| 74 | MP0002269_muscular_atrophy | 1.16954165 |
| 75 | MP0002722_abnormal_immune_system | 1.16491740 |
| 76 | MP0002106_abnormal_muscle_physiology | 1.16001402 |
| 77 | MP0005187_abnormal_penis_morphology | 1.15464061 |
| 78 | MP0004043_abnormal_pH_regulation | 1.15166694 |
| 79 | MP0003115_abnormal_respiratory_system | 1.14749158 |
| 80 | MP0000759_abnormal_skeletal_muscle | 1.13977847 |
| 81 | MP0005646_abnormal_pituitary_gland | 1.13913859 |
| 82 | MP0000015_abnormal_ear_pigmentation | 1.12214388 |
| 83 | MP0003786_premature_aging | 1.12057286 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.09827256 |
| 85 | MP0003122_maternal_imprinting | 1.06221930 |
| 86 | MP0002210_abnormal_sex_determination | 1.06160238 |
| 87 | MP0005220_abnormal_exocrine_pancreas | 1.06014655 |
| 88 | MP0002019_abnormal_tumor_incidence | 1.05521419 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 1.04331794 |
| 90 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04001740 |
| 91 | MP0010630_abnormal_cardiac_muscle | 1.02459716 |
| 92 | MP0001764_abnormal_homeostasis | 1.01716053 |
| 93 | MP0000703_abnormal_thymus_morphology | 1.01064226 |
| 94 | MP0000490_abnormal_crypts_of | 1.00189418 |
| 95 | MP0001145_abnormal_male_reproductive | 1.00106987 |
| 96 | MP0002009_preneoplasia | 0.99905837 |
| 97 | MP0003943_abnormal_hepatobiliary_system | 0.98458184 |
| 98 | MP0002166_altered_tumor_susceptibility | 0.97180804 |
| 99 | MP0000427_abnormal_hair_cycle | 0.96926913 |
| 100 | MP0003787_abnormal_imprinting | 0.96474237 |
| 101 | MP0002234_abnormal_pharynx_morphology | 0.95918959 |
| 102 | MP0009703_decreased_birth_body | 0.93361886 |
| 103 | MP0002102_abnormal_ear_morphology | 0.93173041 |
| 104 | MP0002429_abnormal_blood_cell | 0.92963177 |
| 105 | MP0000749_muscle_degeneration | 0.92677616 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 0.92629891 |
| 107 | MP0002970_abnormal_white_adipose | 0.91872112 |
| 108 | MP0004185_abnormal_adipocyte_glucose | 0.91865943 |
| 109 | MP0005369_muscle_phenotype | 0.91689475 |
| 110 | MP0004036_abnormal_muscle_relaxation | 0.90234359 |
| 111 | MP0008775_abnormal_heart_ventricle | 0.89030433 |
| 112 | MP0003935_abnormal_craniofacial_develop | 0.88837832 |
| 113 | MP0008438_abnormal_cutaneous_collagen | 0.87629347 |
| 114 | MP0000653_abnormal_sex_gland | 0.87570474 |
| 115 | MP0008770_decreased_survivor_rate | 0.87559302 |
| 116 | MP0005408_hypopigmentation | 0.87380161 |
| 117 | MP0003698_abnormal_male_reproductive | 0.87053047 |
| 118 | MP0001293_anophthalmia | 0.86515023 |
| 119 | MP0000358_abnormal_cell_content/ | 0.86279394 |
| 120 | MP0002736_abnormal_nociception_after | 0.85995131 |
| 121 | MP0000266_abnormal_heart_morphology | 0.85174449 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.85080774 |
| 123 | MP0001835_abnormal_antigen_presentation | 0.83390184 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.82571518 |
| 125 | MP0008961_abnormal_basal_metabolism | 0.82561767 |
| 126 | MP0009053_abnormal_anal_canal | 0.80601271 |
| 127 | MP0002092_abnormal_eye_morphology | 0.80587061 |
| 128 | MP0005389_reproductive_system_phenotype | 0.78913443 |
| 129 | MP0003866_abnormal_defecation | 0.77717337 |
| 130 | MP0002132_abnormal_respiratory_system | 0.77329833 |
| 131 | MP0002925_abnormal_cardiovascular_devel | 0.75997327 |
| 132 | MP0003861_abnormal_nervous_system | 0.75726102 |
| 133 | MP0000598_abnormal_liver_morphology | 0.75497796 |
| 134 | MP0002095_abnormal_skin_pigmentation | 0.74250101 |
| 135 | MP0003959_abnormal_lean_body | 0.74130657 |
| 136 | MP0005503_abnormal_tendon_morphology | 0.73894540 |
| 137 | MP0005266_abnormal_metabolism | 0.73583987 |
| 138 | MP0002006_tumorigenesis | 0.72486951 |
| 139 | MP0001529_abnormal_vocalization | 0.72047939 |
| 140 | MP0005174_abnormal_tail_pigmentation | 0.72017780 |
| 141 | MP0005330_cardiomyopathy | 0.71956499 |
| 142 | MP0000569_abnormal_digit_pigmentation | 0.71889627 |
| 143 | MP0003942_abnormal_urinary_system | 0.71671747 |
| 144 | MP0002938_white_spotting | 0.71565098 |
| 145 | MP0002114_abnormal_axial_skeleton | 0.70756134 |
| 146 | MP0005384_cellular_phenotype | 0.70221060 |
| 147 | MP0002932_abnormal_joint_morphology | 0.69995957 |
| 148 | MP0004215_abnormal_myocardial_fiber | 0.69641709 |
| 149 | MP0001119_abnormal_female_reproductive | 0.69437558 |
| 150 | MP0010234_abnormal_vibrissa_follicle | 0.69087339 |
| 151 | MP0003385_abnormal_body_wall | 0.68545094 |
| 152 | MP0005275_abnormal_skin_tensile | 0.68441022 |
| 153 | MP0005397_hematopoietic_system_phenotyp | 0.68147305 |
| 154 | MP0001545_abnormal_hematopoietic_system | 0.68147305 |
| 155 | MP0008873_increased_physiological_sensi | 0.67713591 |
| 156 | MP0005551_abnormal_eye_electrophysiolog | 0.67258266 |
| 157 | MP0005332_abnormal_amino_acid | 0.67067786 |
| 158 | MP0004264_abnormal_extraembryonic_tissu | 0.66407378 |
| 159 | MP0000383_abnormal_hair_follicle | 0.65799734 |
| 160 | MP0005395_other_phenotype | 0.65742533 |
| 161 | MP0003646_muscle_fatigue | 0.64979159 |
| 162 | MP0002163_abnormal_gland_morphology | 0.63768556 |
| 163 | MP0005636_abnormal_mineral_homeostasis | 0.63588961 |
| 164 | MP0001881_abnormal_mammary_gland | 0.63206627 |
| 165 | MP0000716_abnormal_immune_system | 0.62703519 |
| 166 | MP0002083_premature_death | 0.62632707 |
| 167 | MP0002075_abnormal_coat/hair_pigmentati | 0.61204983 |
| 168 | MP0006072_abnormal_retinal_apoptosis | 0.57042706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.14402668 |
| 2 | Chromsome breakage (HP:0040012) | 3.84055019 |
| 3 | Microvesicular hepatic steatosis (HP:0001414) | 3.76282412 |
| 4 | Renal cortical cysts (HP:0000803) | 3.71554154 |
| 5 | Hyperacusis (HP:0010780) | 3.51509664 |
| 6 | Short 4th metacarpal (HP:0010044) | 3.36321764 |
| 7 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 3.36321764 |
| 8 | Medulloblastoma (HP:0002885) | 3.32932415 |
| 9 | Ependymoma (HP:0002888) | 3.27550827 |
| 10 | Type I transferrin isoform profile (HP:0003642) | 3.24028691 |
| 11 | Abnormal protein glycosylation (HP:0012346) | 3.15641120 |
| 12 | Abnormal glycosylation (HP:0012345) | 3.15641120 |
| 13 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.15641120 |
| 14 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.15641120 |
| 15 | Hepatic necrosis (HP:0002605) | 3.12369783 |
| 16 | Increased nuchal translucency (HP:0010880) | 3.07172893 |
| 17 | Dyschromatopsia (HP:0007641) | 3.06125916 |
| 18 | Panhypogammaglobulinemia (HP:0003139) | 2.97915933 |
| 19 | Hepatocellular necrosis (HP:0001404) | 2.97913372 |
| 20 | Abnormality of the calcaneus (HP:0008364) | 2.95443930 |
| 21 | Myelodysplasia (HP:0002863) | 2.95304867 |
| 22 | Colon cancer (HP:0003003) | 2.89559392 |
| 23 | Increased serum lactate (HP:0002151) | 2.88524248 |
| 24 | Renal duplication (HP:0000075) | 2.86991542 |
| 25 | Reticulocytopenia (HP:0001896) | 2.82084590 |
| 26 | Pelvic girdle muscle weakness (HP:0003749) | 2.80314455 |
| 27 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.79837510 |
| 28 | Abnormality of alanine metabolism (HP:0010916) | 2.79837510 |
| 29 | Hyperalaninemia (HP:0003348) | 2.79837510 |
| 30 | Shoulder girdle muscle weakness (HP:0003547) | 2.78596865 |
| 31 | Calcaneovalgus deformity (HP:0001848) | 2.78179028 |
| 32 | Abnormality of the preputium (HP:0100587) | 2.77495096 |
| 33 | Myopathic facies (HP:0002058) | 2.73985737 |
| 34 | Pancytopenia (HP:0001876) | 2.73549011 |
| 35 | Abnormality of the renal cortex (HP:0011035) | 2.68041110 |
| 36 | Ankle contracture (HP:0006466) | 2.66492383 |
| 37 | 3-Methylglutaconic aciduria (HP:0003535) | 2.64464484 |
| 38 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.63044621 |
| 39 | Type 1 muscle fiber predominance (HP:0003803) | 2.61924093 |
| 40 | Insomnia (HP:0100785) | 2.59177026 |
| 41 | Deformed tarsal bones (HP:0008119) | 2.58483452 |
| 42 | Abnormality of the 4th metacarpal (HP:0010012) | 2.54643128 |
| 43 | Testicular atrophy (HP:0000029) | 2.50858023 |
| 44 | Lactic acidosis (HP:0003128) | 2.50789600 |
| 45 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.47816509 |
| 46 | Elfin facies (HP:0004428) | 2.45859912 |
| 47 | Increased CSF lactate (HP:0002490) | 2.44938384 |
| 48 | Selective tooth agenesis (HP:0001592) | 2.43099812 |
| 49 | Glioma (HP:0009733) | 2.42592415 |
| 50 | Ulnar deviation of the wrist (HP:0003049) | 2.42469905 |
| 51 | Meckel diverticulum (HP:0002245) | 2.42322039 |
| 52 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.42175527 |
| 53 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.42175527 |
| 54 | Bowel diverticulosis (HP:0005222) | 2.41886997 |
| 55 | Duplicated collecting system (HP:0000081) | 2.41547123 |
| 56 | Overriding aorta (HP:0002623) | 2.40125090 |
| 57 | Abnormality of the ileum (HP:0001549) | 2.38768048 |
| 58 | Basal cell carcinoma (HP:0002671) | 2.37220865 |
| 59 | Astrocytoma (HP:0009592) | 2.36791435 |
| 60 | Abnormality of the astrocytes (HP:0100707) | 2.36791435 |
| 61 | Breast hypoplasia (HP:0003187) | 2.36154681 |
| 62 | Small intestinal stenosis (HP:0012848) | 2.32360419 |
| 63 | Duodenal stenosis (HP:0100867) | 2.32360419 |
| 64 | Rimmed vacuoles (HP:0003805) | 2.31078508 |
| 65 | Abnormality of chromosome stability (HP:0003220) | 2.29719157 |
| 66 | Protrusio acetabuli (HP:0003179) | 2.28972686 |
| 67 | Ragged-red muscle fibers (HP:0003200) | 2.28128727 |
| 68 | Exercise-induced muscle cramps (HP:0003710) | 2.27503822 |
| 69 | Angiofibromas (HP:0010615) | 2.26567932 |
| 70 | Adenoma sebaceum (HP:0009720) | 2.26567932 |
| 71 | Proximal placement of thumb (HP:0009623) | 2.24587803 |
| 72 | Acute encephalopathy (HP:0006846) | 2.23727993 |
| 73 | Progressive microcephaly (HP:0000253) | 2.23678749 |
| 74 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.23627548 |
| 75 | Renovascular hypertension (HP:0100817) | 2.22787621 |
| 76 | Abnormality of T cell physiology (HP:0011840) | 2.22692786 |
| 77 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.19980992 |
| 78 | Limb-girdle muscle atrophy (HP:0003797) | 2.19959778 |
| 79 | Pancreatic cysts (HP:0001737) | 2.18313933 |
| 80 | Muscle fiber inclusion bodies (HP:0100299) | 2.18061135 |
| 81 | Limb-girdle muscle weakness (HP:0003325) | 2.17909804 |
| 82 | Cerebral aneurysm (HP:0004944) | 2.17841565 |
| 83 | Shallow orbits (HP:0000586) | 2.17647354 |
| 84 | Mitochondrial inheritance (HP:0001427) | 2.16530297 |
| 85 | Neoplasm of striated muscle (HP:0009728) | 2.15931649 |
| 86 | Agammaglobulinemia (HP:0004432) | 2.15259769 |
| 87 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.14916806 |
| 88 | Increased density of long bones (HP:0006392) | 2.14757219 |
| 89 | Volvulus (HP:0002580) | 2.14584120 |
| 90 | Sloping forehead (HP:0000340) | 2.14373537 |
| 91 | Rhabdomyosarcoma (HP:0002859) | 2.13462206 |
| 92 | Progressive muscle weakness (HP:0003323) | 2.12576850 |
| 93 | Prolonged bleeding time (HP:0003010) | 2.12169913 |
| 94 | Abnormal number of erythroid precursors (HP:0012131) | 2.11218309 |
| 95 | Petechiae (HP:0000967) | 2.11176775 |
| 96 | Clubbing of toes (HP:0100760) | 2.10852342 |
| 97 | Abnormality of B cell number (HP:0010975) | 2.10734789 |
| 98 | Distal arthrogryposis (HP:0005684) | 2.09316218 |
| 99 | Deviation of the thumb (HP:0009603) | 2.08712219 |
| 100 | Acute lymphatic leukemia (HP:0006721) | 2.08040180 |
| 101 | Pointed chin (HP:0000307) | 2.05011695 |
| 102 | Flat cornea (HP:0007720) | 2.04302259 |
| 103 | Wrist flexion contracture (HP:0001239) | 2.03647736 |
| 104 | Difficulty climbing stairs (HP:0003551) | 2.03376112 |
| 105 | Microretrognathia (HP:0000308) | 2.02496791 |
| 106 | Reduced antithrombin III activity (HP:0001976) | 2.02085296 |
| 107 | Adducted thumb (HP:0001181) | 1.99186043 |
| 108 | Cerebral hypomyelination (HP:0006808) | 1.99017028 |
| 109 | Absent thumb (HP:0009777) | 1.98882825 |
| 110 | Missing ribs (HP:0000921) | 1.98300163 |
| 111 | Intestinal polyp (HP:0005266) | 1.98264638 |
| 112 | Abnormality of the renal collecting system (HP:0004742) | 1.97748451 |
| 113 | Bladder diverticulum (HP:0000015) | 1.96980061 |
| 114 | 11 pairs of ribs (HP:0000878) | 1.96529459 |
| 115 | High pitched voice (HP:0001620) | 1.96187244 |
| 116 | Cutaneous melanoma (HP:0012056) | 1.94122363 |
| 117 | CNS demyelination (HP:0007305) | 1.93361926 |
| 118 | Central scotoma (HP:0000603) | 1.93308334 |
| 119 | Slender long bone (HP:0003100) | 1.92951711 |
| 120 | Opisthotonus (HP:0002179) | 1.92705261 |
| 121 | Intestinal polyposis (HP:0200008) | 1.92591820 |
| 122 | Tinnitus (HP:0000360) | 1.92512392 |
| 123 | B lymphocytopenia (HP:0010976) | 1.92361351 |
| 124 | Brushfield spots (HP:0001088) | 1.92308516 |
| 125 | Increased intramyocellular lipid droplets (HP:0012240) | 1.92047977 |
| 126 | Cerebral palsy (HP:0100021) | 1.92034006 |
| 127 | Nemaline bodies (HP:0003798) | 1.91712180 |
| 128 | Acute necrotizing encephalopathy (HP:0006965) | 1.89600161 |
| 129 | Increased connective tissue (HP:0009025) | 1.89432543 |
| 130 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89352442 |
| 131 | Dicarboxylic aciduria (HP:0003215) | 1.89352442 |
| 132 | Bile duct proliferation (HP:0001408) | 1.89247853 |
| 133 | Abnormal biliary tract physiology (HP:0012439) | 1.89247853 |
| 134 | Ketosis (HP:0001946) | 1.89133551 |
| 135 | Broad palm (HP:0001169) | 1.88686562 |
| 136 | Patellar aplasia (HP:0006443) | 1.88251673 |
| 137 | Megalocornea (HP:0000485) | 1.87975300 |
| 138 | IgA deficiency (HP:0002720) | 1.87421899 |
| 139 | Ketoacidosis (HP:0001993) | 1.85871964 |
| 140 | Neoplasm of the pancreas (HP:0002894) | 1.85584237 |
| 141 | Severe combined immunodeficiency (HP:0004430) | 1.85312743 |
| 142 | Abnormality of DNA repair (HP:0003254) | 1.84649261 |
| 143 | Premature ovarian failure (HP:0008209) | 1.84356415 |
| 144 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.84306598 |
| 145 | IgM deficiency (HP:0002850) | 1.83839763 |
| 146 | Abnormality of methionine metabolism (HP:0010901) | 1.83817112 |
| 147 | Hyperglycinuria (HP:0003108) | 1.83514778 |
| 148 | Squamous cell carcinoma (HP:0002860) | 1.83411105 |
| 149 | Enlarged penis (HP:0000040) | 1.83164319 |
| 150 | Spastic paraparesis (HP:0002313) | 1.82580366 |
| 151 | Emotional lability (HP:0000712) | 1.81979474 |
| 152 | Abnormality of glycolysis (HP:0004366) | 1.79639852 |
| 153 | CNS hypomyelination (HP:0003429) | 1.79427627 |
| 154 | Birth length less than 3rd percentile (HP:0003561) | 1.79411745 |
| 155 | Trigonocephaly (HP:0000243) | 1.77819848 |
| 156 | Subaortic stenosis (HP:0001682) | 1.77175800 |
| 157 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.77175800 |
| 158 | Neoplasm of the heart (HP:0100544) | 1.76930969 |
| 159 | Acute hepatic failure (HP:0006554) | 1.76293475 |
| 160 | Bicuspid aortic valve (HP:0001647) | 1.76036402 |
| 161 | Degeneration of anterior horn cells (HP:0002398) | 1.75593280 |
| 162 | Abnormality of the anterior horn cell (HP:0006802) | 1.75593280 |
| 163 | Cerebellar dysplasia (HP:0007033) | 1.74993095 |
| 164 | Fibroma (HP:0010614) | 1.74770645 |
| 165 | IgG deficiency (HP:0004315) | 1.74630668 |
| 166 | Hyperammonemia (HP:0001987) | 1.74621657 |
| 167 | Nephronophthisis (HP:0000090) | 1.74403329 |
| 168 | Abnormality of the pons (HP:0007361) | 1.74377158 |
| 169 | Abnormality of the carotid arteries (HP:0005344) | 1.74250603 |
| 170 | Secondary amenorrhea (HP:0000869) | 1.74084141 |
| 171 | Fibrous tissue neoplasm (HP:0012316) | 1.73829480 |
| 172 | Difficulty running (HP:0009046) | 1.73206688 |
| 173 | Bone marrow hypocellularity (HP:0005528) | 1.71705048 |
| 174 | Cafe-au-lait spot (HP:0000957) | 1.71514128 |
| 175 | Atresia of the external auditory canal (HP:0000413) | 1.71421712 |
| 176 | Freckling (HP:0001480) | 1.67451320 |
| 177 | Ovarian neoplasm (HP:0100615) | 1.65778636 |
| 178 | Long toe (HP:0010511) | 1.65098060 |
| 179 | Aplastic anemia (HP:0001915) | 1.62556459 |
| 180 | Slender build (HP:0001533) | 1.61969325 |
| 181 | Exercise-induced myalgia (HP:0003738) | 1.61840613 |
| 182 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.61714298 |
| 183 | Rectal prolapse (HP:0002035) | 1.61618600 |
| 184 | Genu recurvatum (HP:0002816) | 1.60386436 |
| 185 | Sacral dimple (HP:0000960) | 1.59790429 |
| 186 | Lymphangioma (HP:0100764) | 1.59298459 |
| 187 | Thrombocytosis (HP:0001894) | 1.58496065 |
| 188 | Prominent nose (HP:0000448) | 1.58149730 |
| 189 | Carpal bone hypoplasia (HP:0001498) | 1.57736029 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.87362270 |
| 2 | CDC7 | 3.64598908 |
| 3 | EEF2K | 3.60032309 |
| 4 | PKN2 | 3.57091821 |
| 5 | ZAK | 3.30348942 |
| 6 | PBK | 3.27434157 |
| 7 | BUB1 | 2.99261656 |
| 8 | NEK1 | 2.74705545 |
| 9 | NEK2 | 2.67613605 |
| 10 | WEE1 | 2.61634834 |
| 11 | MAP3K10 | 2.60888160 |
| 12 | SCYL2 | 2.53383502 |
| 13 | TTN | 2.48832463 |
| 14 | VRK2 | 2.47161957 |
| 15 | PASK | 2.36967809 |
| 16 | BCKDK | 2.35017902 |
| 17 | NUAK1 | 2.26929898 |
| 18 | NME1 | 2.18934296 |
| 19 | EIF2AK3 | 2.06807704 |
| 20 | BMPR1B | 2.01498228 |
| 21 | FRK | 1.90004151 |
| 22 | BRSK2 | 1.86613151 |
| 23 | SRPK1 | 1.81929373 |
| 24 | TAOK3 | 1.80247528 |
| 25 | PLK4 | 1.76300984 |
| 26 | BRSK1 | 1.69211185 |
| 27 | FLT3 | 1.65210635 |
| 28 | TEC | 1.61868591 |
| 29 | ACVR1B | 1.60733481 |
| 30 | CDK4 | 1.57278740 |
| 31 | TGFBR1 | 1.57222416 |
| 32 | TESK2 | 1.55833122 |
| 33 | TXK | 1.53764647 |
| 34 | LRRK2 | 1.50518945 |
| 35 | ATR | 1.46745812 |
| 36 | TTK | 1.46278572 |
| 37 | DYRK3 | 1.44373991 |
| 38 | MAP4K2 | 1.42657100 |
| 39 | FES | 1.42215427 |
| 40 | VRK1 | 1.41869571 |
| 41 | RPS6KB2 | 1.36347720 |
| 42 | PDK2 | 1.33149547 |
| 43 | EIF2AK1 | 1.29536801 |
| 44 | PAK4 | 1.28584894 |
| 45 | AURKB | 1.27918684 |
| 46 | PLK1 | 1.25739806 |
| 47 | CDK6 | 1.18096952 |
| 48 | CDK8 | 1.13417869 |
| 49 | TLK1 | 1.12100053 |
| 50 | CDK12 | 1.11559349 |
| 51 | CHEK2 | 1.11060599 |
| 52 | DAPK1 | 1.10580538 |
| 53 | MAP3K8 | 1.08186269 |
| 54 | TSSK6 | 1.07916099 |
| 55 | MAP3K6 | 1.05395437 |
| 56 | RPS6KA4 | 1.03529925 |
| 57 | BTK | 1.00899270 |
| 58 | RIPK1 | 1.00452714 |
| 59 | ALK | 0.99700706 |
| 60 | ILK | 0.97620701 |
| 61 | MKNK1 | 0.96013603 |
| 62 | PDGFRA | 0.95650988 |
| 63 | CHEK1 | 0.90247420 |
| 64 | CDK7 | 0.89830425 |
| 65 | CCNB1 | 0.89578844 |
| 66 | MAPKAPK3 | 0.85545041 |
| 67 | TESK1 | 0.85007327 |
| 68 | RIPK4 | 0.83635133 |
| 69 | STK16 | 0.83006526 |
| 70 | MTOR | 0.82628640 |
| 71 | MAP2K6 | 0.82093811 |
| 72 | NME2 | 0.81595519 |
| 73 | BMPR2 | 0.81428668 |
| 74 | MAP2K3 | 0.80889986 |
| 75 | MAPKAPK5 | 0.80163447 |
| 76 | RAF1 | 0.79865430 |
| 77 | AURKA | 0.79474087 |
| 78 | PTK6 | 0.79395341 |
| 79 | STK10 | 0.78950744 |
| 80 | BMX | 0.76733891 |
| 81 | CDK2 | 0.74421372 |
| 82 | EIF2AK2 | 0.74285012 |
| 83 | PAK2 | 0.69668949 |
| 84 | SYK | 0.69340593 |
| 85 | KSR1 | 0.69074531 |
| 86 | LIMK1 | 0.68830584 |
| 87 | PIM2 | 0.68504481 |
| 88 | TRPM7 | 0.67415737 |
| 89 | WNK4 | 0.66476617 |
| 90 | PLK3 | 0.66098602 |
| 91 | TAOK1 | 0.65058071 |
| 92 | UHMK1 | 0.64580056 |
| 93 | PHKG1 | 0.63166021 |
| 94 | PHKG2 | 0.63166021 |
| 95 | STK4 | 0.62085362 |
| 96 | MAP4K1 | 0.61332823 |
| 97 | SMG1 | 0.60149545 |
| 98 | RET | 0.59830787 |
| 99 | MAP2K2 | 0.59548431 |
| 100 | CDK9 | 0.59450316 |
| 101 | MKNK2 | 0.58645422 |
| 102 | ITK | 0.58071785 |
| 103 | INSRR | 0.57399315 |
| 104 | CDK11A | 0.56570352 |
| 105 | MAP3K11 | 0.56033945 |
| 106 | MAPK13 | 0.55486471 |
| 107 | GRK6 | 0.55207185 |
| 108 | CDK15 | 0.54544708 |
| 109 | MAP3K4 | 0.53708577 |
| 110 | AKT2 | 0.53426612 |
| 111 | CDK1 | 0.53042850 |
| 112 | * ATM | 0.52362492 |
| 113 | PTK2B | 0.51798237 |
| 114 | CDK18 | 0.50772702 |
| 115 | CDK14 | 0.50257997 |
| 116 | CAMKK2 | 0.48821301 |
| 117 | PAK1 | 0.48521246 |
| 118 | CSNK1G3 | 0.48072198 |
| 119 | KSR2 | 0.46015426 |
| 120 | RPS6KA5 | 0.45585375 |
| 121 | FGFR1 | 0.44216685 |
| 122 | BRD4 | 0.43391558 |
| 123 | MST4 | 0.42707829 |
| 124 | DYRK1B | 0.42581846 |
| 125 | PIK3CG | 0.41945309 |
| 126 | MARK1 | 0.41054016 |
| 127 | PRKCI | 0.40845092 |
| 128 | OBSCN | 0.40821577 |
| 129 | MAPK9 | 0.40626770 |
| 130 | * PRKDC | 0.40117332 |
| 131 | MAP2K1 | 0.40010925 |
| 132 | KDR | 0.39866426 |
| 133 | CSNK2A1 | 0.39566643 |
| 134 | CLK1 | 0.37989385 |
| 135 | PDK3 | 0.37647045 |
| 136 | PDK4 | 0.37647045 |
| 137 | KIT | 0.36708164 |
| 138 | CSNK2A2 | 0.35604457 |
| 139 | RPS6KA2 | 0.34860962 |
| 140 | MAP3K5 | 0.33734085 |
| 141 | CSNK1A1L | 0.32938841 |
| 142 | HCK | 0.32658803 |
| 143 | IKBKB | 0.31548003 |
| 144 | CSNK1G1 | 0.31293179 |
| 145 | HIPK2 | 0.30990213 |
| 146 | MARK3 | 0.29783374 |
| 147 | RPS6KA1 | 0.29630449 |
| 148 | CSNK1E | 0.28527199 |
| 149 | PRKCQ | 0.28137492 |
| 150 | MAPK11 | 0.27567867 |
| 151 | MAPKAPK2 | 0.27301222 |
| 152 | ZAP70 | 0.26400915 |
| 153 | MELK | 0.26300481 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.03954170 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.64193643 |
| 3 | Spliceosome_Homo sapiens_hsa03040 | 2.87405289 |
| 4 | * Cell cycle_Homo sapiens_hsa04110 | 2.80539417 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.80268616 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 2.61672692 |
| 7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.33829074 |
| 8 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.33717606 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.22308424 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.02544417 |
| 11 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.96027381 |
| 12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.94880062 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.74069443 |
| 14 | * Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.73747688 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.69804508 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.69167438 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57990640 |
| 18 | * Oocyte meiosis_Homo sapiens_hsa04114 | 1.52830348 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.52492716 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.48357686 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.41259299 |
| 22 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.40001366 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.36671824 |
| 24 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.31155800 |
| 25 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.29367595 |
| 26 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26868058 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.26468158 |
| 28 | Colorectal cancer_Homo sapiens_hsa05210 | 1.24791850 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.23780915 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.23393846 |
| 31 | Proteasome_Homo sapiens_hsa03050 | 1.22739964 |
| 32 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.21210737 |
| 33 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.18099032 |
| 34 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.17487797 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11088039 |
| 36 | Protein export_Homo sapiens_hsa03060 | 1.11001816 |
| 37 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.10809109 |
| 38 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.09528960 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.08122121 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07429379 |
| 41 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06379038 |
| 42 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.05117160 |
| 43 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.05057349 |
| 44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.04629984 |
| 45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.04404436 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.03273928 |
| 47 | RNA polymerase_Homo sapiens_hsa03020 | 1.02148600 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 1.01939833 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01797803 |
| 50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.01700982 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99965625 |
| 52 | Thyroid cancer_Homo sapiens_hsa05216 | 0.99794378 |
| 53 | Alcoholism_Homo sapiens_hsa05034 | 0.99135419 |
| 54 | Bladder cancer_Homo sapiens_hsa05219 | 0.98539169 |
| 55 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98359883 |
| 56 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97797320 |
| 57 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92789926 |
| 58 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.92359570 |
| 59 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.91707030 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.90844956 |
| 61 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88719382 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.88202600 |
| 63 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86293553 |
| 64 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.86055397 |
| 65 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.85629266 |
| 66 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.83609506 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.83167311 |
| 68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.82305579 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.82256578 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81802568 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81712318 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.80670089 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.79310797 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79224828 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.77886355 |
| 76 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.77286937 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.77233510 |
| 78 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.77006676 |
| 79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.73670045 |
| 80 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.72131268 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71842116 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71453681 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69850344 |
| 84 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.69366603 |
| 85 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.68437763 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.67843285 |
| 87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.67602936 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.66524945 |
| 89 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.64102372 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63645226 |
| 91 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62748865 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.62287239 |
| 93 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61514701 |
| 94 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61126671 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.60046216 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.59492717 |
| 97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59387949 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58781569 |
| 99 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57638105 |
| 100 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57627247 |
| 101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56335833 |
| 102 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56303565 |
| 103 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56263951 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.55190077 |
| 105 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55181867 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.55143293 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.54784081 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54768775 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.54234192 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.53967819 |
| 111 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.53621832 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.52755553 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51359332 |
| 114 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.49909515 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49871013 |
| 116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.48913375 |
| 117 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48708235 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.48674241 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48503586 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48093925 |
| 121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.48017619 |
| 122 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47104700 |
| 123 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45707938 |
| 124 | Platelet activation_Homo sapiens_hsa04611 | 0.45606154 |
| 125 | Phototransduction_Homo sapiens_hsa04744 | 0.45387116 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43887816 |
| 127 | Tight junction_Homo sapiens_hsa04530 | 0.43646822 |
| 128 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43412967 |
| 129 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42953784 |
| 130 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42205053 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.41357035 |
| 132 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.40944293 |
| 133 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.40896877 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.40715024 |
| 135 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39392678 |
| 136 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.39070873 |
| 137 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36675725 |
| 138 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.36617937 |
| 139 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35218907 |
| 140 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34696325 |
| 141 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33879820 |
| 142 | Alzheimers disease_Homo sapiens_hsa05010 | 0.30966867 |
| 143 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30248711 |
| 144 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30179823 |
| 145 | ABC transporters_Homo sapiens_hsa02010 | 0.30043347 |
| 146 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29580870 |
| 147 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27967050 |
| 148 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.23500548 |
| 149 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21992771 |
| 150 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.19763152 |
| 151 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.19323418 |
| 152 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.19207087 |
| 153 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.17721282 |
| 154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17407194 |
| 155 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.15415544 |
| 156 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15374223 |
| 157 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.15050625 |
| 158 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.13977597 |
| 159 | Other glycan degradation_Homo sapiens_hsa00511 | 0.13963816 |
| 160 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.12671872 |

